The West Clinic, PLLC
The West Clinic, PLLC was paid $16.03M by Medicaid between Jan 2018 and Dec 2024, across 129 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 18% of everything it billed.
33Billing provider infoTHE WEST CLINIC, PLLC
GERMANTOWN, TN 38138
GERMANTOWN, TN 38138
33aNPI1447276605assigned 07/14/2006
33bProvider typeSpecialist
28Total paid$16.03M
24GClaims692,502
24DCodes billed129
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Tennessee
Rank by total paid#4 of 252
Median peer was paid$57K
This provider vs. median281×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,009 | $1.16M | |
| 2019 | 146,600 | $3.86M | |
| 2020 | 149,498 | $3.76M | |
| 2021 | 115,726 | $2.68M | |
| 2022 | 93,560 | $1.91M | |
| 2023 | 86,858 | $1.63M | |
| 2024incomplete | 62,251 | $1.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 86,532 | 67,617 | $2.95M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 14% | 31,729 | 18,847 | $2.24M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.4% | 13,995 | 10,405 | $1.50M |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 7.9% | 15,795 | 11,826 | $1.27M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.4% | 102,725 | 67,350 | $865K |
| 96367 | 4.8% | 23,335 | 14,062 | $767K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.3% | 23,714 | 19,248 | $530K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.3% | 10,648 | 7,891 | $523K |
| 77014 | 3.1% | 14,585 | 4,037 | $505K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 2.9% | 1,219 | 834 | $463K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.3% | 14,791 | 4,928 | $366K |
| 77066 | Tomosynthesis, mammo | 1.4% | 3,148 | 2,355 | $225K |
117 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | 1.3% | 80,086 | $211K |
| J9271 | Injection, pembrolizumab, 1 mg | 1.3% | 64 | $204K |
| J0897 | Injection, denosumab, 1 mg | 1.3% | 287 | $201K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 13,879 | $201K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 5,011 | $187K |
| 80076 | 1.1% | 60,697 | $172K | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 376 | $146K |
| 99223 | Prolong inpt eval add15 m | <1% | 2,378 | $144K |
| 36415 | Collection of venous blood by venipuncture | <1% | 69,276 | $140K |
| 96417 | <1% | 3,470 | $129K | |
| J2505 | Injection, pegfilgrastim, 6 mg | <1% | 69 | $120K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 2,985 | $120K |
| 76642 | <1% | 2,377 | $118K | |
| 36561 | <1% | 313 | $116K | |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | <1% | 678 | $115K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,442 | $102K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 18,562 | $98K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 2,269 | $89K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 962 | $82K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,511 | $82K |
| 77427 | <1% | 903 | $64K | |
| 88341 | <1% | 1,123 | $63K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 921 | $58K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 245 | $58K |
| 96415 | <1% | 2,625 | $56K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 3,413 | $53K |
| 77065 | Tomosynthesis, mammo | <1% | 882 | $50K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | <1% | 269 | $48K |
| 70491 | <1% | 458 | $39K | |
| 88342 | <1% | 1,338 | $36K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14,762 | $35K |
| 77012 | <1% | 667 | $30K | |
| 82728 | <1% | 4,559 | $24K | |
| 77062 | <1% | 259 | $22K | |
| 96368 | <1% | 2,305 | $22K | |
| J9395 | Injection, fulvestrant, 25 mg | <1% | 16 | $19K |
| 96401 | <1% | 543 | $18K | |
| 99205 | Prolong outpt/office vis | <1% | 253 | $16K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | <1% | 141 | $16K |
| 99152 | <1% | 1,082 | $16K | |
| 83550 | <1% | 4,843 | $15K | |
| J0185 | Injection, aprepitant, 1 mg | <1% | 117 | $15K |
| 96402 | <1% | 674 | $14K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 169 | $14K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 782 | $14K |
| 82378 | <1% | 1,963 | $13K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 235 | $12K |
| 77336 | <1% | 302 | $12K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 856 | $11K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 35 | $11K |
| 83540 | <1% | 4,862 | $11K | |
| 77001 | <1% | 426 | $11K | |
| 31575 | <1% | 266 | $11K | |
| 77334 | <1% | 107 | $11K | |
| 76942 | <1% | 272 | $8K | |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 178 | $7K |
| 74160 | <1% | 93 | $7K | |
| 80053 | Comprehensive metabolic panel | <1% | 3,108 | $7K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,558 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 950 | $6K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 168 | $6K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 782 | $5K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 136 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 504 | $5K |
| 96416 | <1% | 30 | $4K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,779 | $4K |
| G6012 | Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | <1% | 36 | $4K |
| 90756 | <1% | 331 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 259 | $4K |
| 76937 | <1% | 316 | $3K | |
| 77263 | <1% | 51 | $3K | |
| 32405 | <1% | 31 | $3K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 556 | $3K |
| 86300 | <1% | 381 | $2K | |
| 96411 | <1% | 52 | $2K | |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 225 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 157 | $2K |
| J9267 | Injection, paclitaxel, 1 mg | <1% | 154 | $2K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 31 | $2K |
| 96160 | <1% | 561 | $2K | |
| 83615 | <1% | 1,257 | $2K | |
| 82784 | <1% | 531 | $2K | |
| 82607 | <1% | 249 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 32 | $1K |
| 31525 | <1% | 20 | $1K | |
| 77080 | <1% | 27 | $997.83 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 33 | $982.83 |
| 99221 | <1% | 29 | $959.50 | |
| 86152 | <1% | 18 | $951.51 | |
| 71250 | <1% | 28 | $933.19 | |
| 99224 | <1% | 100 | $838.17 | |
| 83883 | <1% | 269 | $795.68 | |
| 85610 | <1% | 356 | $697.19 | |
| 82565 | <1% | 218 | $608.70 | |
| 99253 | <1% | 16 | $597.00 | |
| J3490 | Unclassified drugs | <1% | 831 | $542.21 |
| 82270 | <1% | 79 | $532.43 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 158 | $531.02 |
| 88313 | <1% | 27 | $460.96 | |
| 82746 | <1% | 92 | $421.79 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 736 | $415.19 |
| 84153 | <1% | 88 | $382.63 | |
| 99358 | Prolong nursin fac eval 15m | <1% | 15 | $373.08 |
| 86304 | <1% | 31 | $273.01 | |
| A4550 | Surgical trays | <1% | 3,959 | $270.33 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 31 | $216.56 |
| 36591 | <1% | 18 | $203.79 | |
| J9045 | Injection, carboplatin, 50 mg | <1% | 15 | $193.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 36 | $185.69 |
| 99459 | <1% | 19 | $185.60 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 590 | $116.54 |
| 83735 | <1% | 57 | $110.97 | |
| 84550 | <1% | 72 | $103.50 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 129 | $98.32 |
| 82232 | <1% | 14 | $42.53 | |
| A4301 | Implantable access total catheter, port/reservoir (e.g., venous, arterial, epidural, subarachnoid, peritoneal, etc.) | 0% | 282 | $0.00 |
| 96040 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRAVES, JOHN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Creative Directions INC. | Burlington, NC | $2.73M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.